WhichRecall
Class IIReported 2025-10-22

Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01

Recalled by Rising Pharma Holding, Inc.

Reason for Recall

Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).

Advertisement
Recall Number
D-0029-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-10-07
Reported
2025-10-22
Distribution
Distributed Nationwide in the USA
Code Info
Lot # CS25070, exp. date 03/31/2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement